CELH
Celsius Holdings, Inc.
CELH has the edge over UTZ overall, supported by stronger fundamentals and stronger valuation.
UTZ
Utz Brands, Inc.
UTZ trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
UTZ Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Weak |
UTZ's revenue and cash flow are currently stable, but its profitability and balance sheet are under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
UTZ PE Valuation
UTZ has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
UTZ Forward outlook
There aren't enough analyst estimates for UTZ to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over UTZ on earnings quality, reporting a profit while its opponent remains loss making.
UTZ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.43 | -638% |
| Q2 2026 | -$0.33 | -250% |
| Q1 2026 | -$0.10 | -130% |
| Q4 2025 | $0.01 | -95% |
| Q3 2025 | $0.08 | +$0.27 |
| Q2 2025 | $0.22 | +633% |
| Q1 2025 | $0.33 | +$0.58 |
| Q4 2024 | $0.19 | +$0.50 |
UTZ has swung to a loss: it lost $0.43 per share over the past year, after a profit the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over UTZ on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over UTZ on profitability, with a higher operating margin.
UTZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $369.2M | -2.3% |
| Q2 2026 | $371.8M | +1.4% |
| Q1 2026 | $361.3M | +2.6% |
| Q4 2025 | $342.2M | +0.3% |
| Q3 2025 | $377.8M | +3.4% |
| Q2 2025 | $366.7M | +3% |
| Q1 2025 | $352.1M | +1.6% |
| Q4 2024 | $341M | -3.1% |
UTZ's revenue grew through 2022 and has held roughly level since: $369M last quarter, down 2.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -5.9% | -6.8 points |
| Q2 2026 | -1.5% | -3.2 points |
| Q1 2026 | 2.2% | +0.6 points |
| Q4 2025 | 1.2% | -0.9 points |
| Q3 2025 | 0.9% | -4.5 points |
| Q2 2025 | 1.8% | -4.6 points |
| Q1 2025 | 1.6% | -1.2 points |
| Q4 2024 | 2.1% | -0.8 points |
UTZ's operating margin was −5.9% last quarter, down 6.8 points from the same quarter a year ago, near the bottom of its range since 2020.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
UTZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$21M | -176% |
| Q2 2026 | -$1.9M | +$8.7M |
| Q1 2026 | -$26M | +$33M |
| Q4 2025 | $51.3M | +212% |
| Q3 2025 | $27.7M | -4.6% |
| Q2 2025 | -$10.6M | +$4.7M |
| Q1 2025 | -$59M | -$36.3M |
| Q4 2024 | $16.4M | -6% |
UTZ's free cash flow has turned positive after five years mostly in the red: $2M over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over UTZ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
UTZ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +102K shares |
| 1 year | +1.9% | +1.7M shares |
| 3 years | +6.2% | +5.2M shares |
| 5 years | +9.5% | +7.7M shares |
| Available history | +49% | +29.2M shares |
UTZ has 89M diluted shares, up 1.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2020 | — |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over UTZ on leverage, with a lower net debt burden relative to earnings.
UTZ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 10.8x | High |
| Q2 2026 | 8.0x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.2x | High |
| Q3 2025 | 7.9x | High |
| Q2 2025 | 7.1x | High |
| Q1 2025 | 6.2x | High |
| Q4 2024 | 5.5x | High |
UTZ's net debt is about 11 years of its operating earnings (EBITDA), up from 7.9 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
UTZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 72.9 | Overbought |
| Stochastic | 66.7 | Neutral |
UTZ's weekly RSI is 73 (overbought) and its Stochastic is 67 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
UTZ PE vs Consumer Defensive Sector
| Metric | UTZ | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
UTZ has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
UTZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.3 | 0.1% below |
| 20 week MA | $13.3 | 7.5% above |
| 50 week MA | $10.5 | 36% above |
| 100 week MA | $11.8 | 21% above |
| 200 week MA | $14.1 | 1% above |
UTZ has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
UTZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.3 | $22.3 | +117% |
| 2021 | $22.3 | $16.4 | -27% |
| 2022 | $16.4 | $16.3 | -0.5% |
| 2023 | $16.3 | $16.2 | -0.4% |
| 2024 | $16.2 | $15.6 | -4.1% |
| 2025 | $15.6 | $10.5 | -33% |
| 2026 YTD | $10.5 | $14.3 | +36% |
UTZ has the edge over CELH on returns for 2026, with the stronger performance.